Spotlight on Radiology

Credits: 0.25 CME
The Radiologist's Role in the ADPKD Care Continuum: From Diagnosis to Monitoring Disease Progression
Neera Dahl, MD
Global Education Group

The Radiologist's Role in the ADPKD Care Continuum: From Diagnosis to Monitoring Disease Progression

Start

Activity Details

Free CME
0.25 AMA PRA Category 1 Credit(s)
Released: November 27, 2019
Expires: November 26, 2020
15 minutes to complete

Jointly Provided by


In Collaboration with


Target Audience

Diagnostic and interventional radiologists

Learning Objectives

  • Recognize the radiographic features of ADPKD and how they differ from other renal conditions
  • Discuss optimal strategies for use of MRI in evaluating potential candidates for initiating ADPKD therapy and for monitoring the course of disease progression over time

Activity Description

A concise, 15-minute Video Curbside Consult activity will provide a relaxed, casual atmosphere for two expert faculty – one radiologist and one nephrologist – to discuss effective partnering for improving care for patients with ADPKD. Faculty will be filmed using comfortable and inviting staging to match the collegial style of their discussion. The activity will use video interspersed with interactive questions to engage learners and measure their levels of knowledge and understanding at multiple points. Content will focus on the role of the radiologist in the ADPKD care continuum, including initial diagnosis and ongoing monitoring for disease progression.

Statement of Educational Need

Radiologists are challenged to conduct appropriate imaging studies of patients with renal disease, including ADPKD. Radiologists are underutilizing MRI for monitoring progression of ADPKD and are unaware of the most accurate methods for conducting such imaging studies.

Agenda

  • Brief introduction of ADPKD
  • Need for nephrologist-radiologist partnership
  • Role of radiologists in the ADPKD care continuum
    • ADPKD diagnosis
      • When to suspect ADPKD
      • Establishing an ADPKD diagnosis
      • Guidelines for different age cohorts
      • Use of ultrasound versus other imaging options
    • Monitoring and measurement of ADPKD disease progression
      • When and how often is imaging needed?
      • Use of MRI versus other imaging options (abdominal ultrasound and computed tomography)
  • Recommendations for ongoing radiologist-nephrologist communication
  • Summary of key teaching points

Faculty

Gary Israel, MD
Yale University School of Medicine
New Haven, CT
  • Disclosure:
    • Nothing to disclose


Neera Dahl, MD
Yale University School of Medicine
New Haven, CT
  • Disclosure:
    • Consultant/Independent Contractor: Otsuka America Pharmaceutical, Inc.
    • Advisory Board: Otsuka America Pharmaceutical, Inc.


Planners/Managers:
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Lindsay Borvansky    Nothing to disclose
Andrea Funk    Nothing to disclose
Liddy Knight    Nothing to disclose
Ashley Cann    Nothing to disclose
Ron Schaumburg    Nothing to disclose
Nicola Sirdevan    Nothing to disclose

Conflict of Interest Policy/Disclosure Statement

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Global Academy for Medical Education. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

In order to receive credit for this activity, participants must complete the activity. Participants must also score at least 70% on the posttest and complete the activity evaluations.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Statement of Commercial Support

This activity is supported by an independent educational grant from Otsuka America Pharmaceutical, Inc.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Global Academy for Medical Education do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information for Questions About the Activity

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari.

Activity Details

Free CME
0.25 AMA PRA Category 1 Credit(s)
Released: November 27, 2019
Expires: November 26, 2020
15 minutes to complete

Jointly Provided by


In Collaboration with


Target Audience

Diagnostic and interventional radiologists

Learning Objectives

  • Recognize the radiographic features of ADPKD and how they differ from other renal conditions
  • Discuss optimal strategies for use of MRI in evaluating potential candidates for initiating ADPKD therapy and for monitoring the course of disease progression over time

Activity Description

A concise, 15-minute Video Curbside Consult activity will provide a relaxed, casual atmosphere for two expert faculty – one radiologist and one nephrologist – to discuss effective partnering for improving care for patients with ADPKD. Faculty will be filmed using comfortable and inviting staging to match the collegial style of their discussion. The activity will use video interspersed with interactive questions to engage learners and measure their levels of knowledge and understanding at multiple points. Content will focus on the role of the radiologist in the ADPKD care continuum, including initial diagnosis and ongoing monitoring for disease progression.

Statement of Educational Need

Radiologists are challenged to conduct appropriate imaging studies of patients with renal disease, including ADPKD. Radiologists are underutilizing MRI for monitoring progression of ADPKD and are unaware of the most accurate methods for conducting such imaging studies.

Agenda

  • Brief introduction of ADPKD
  • Need for nephrologist-radiologist partnership
  • Role of radiologists in the ADPKD care continuum
    • ADPKD diagnosis
      • When to suspect ADPKD
      • Establishing an ADPKD diagnosis
      • Guidelines for different age cohorts
      • Use of ultrasound versus other imaging options
    • Monitoring and measurement of ADPKD disease progression
      • When and how often is imaging needed?
      • Use of MRI versus other imaging options (abdominal ultrasound and computed tomography)
  • Recommendations for ongoing radiologist-nephrologist communication
  • Summary of key teaching points

Faculty

Gary Israel, MD
Yale University School of Medicine
New Haven, CT
  • Disclosure:
    • Nothing to disclose


Neera Dahl, MD
Yale University School of Medicine
New Haven, CT
  • Disclosure:
    • Consultant/Independent Contractor: Otsuka America Pharmaceutical, Inc.
    • Advisory Board: Otsuka America Pharmaceutical, Inc.


Planners/Managers:
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Lindsay Borvansky    Nothing to disclose
Andrea Funk    Nothing to disclose
Liddy Knight    Nothing to disclose
Ashley Cann    Nothing to disclose
Ron Schaumburg    Nothing to disclose
Nicola Sirdevan    Nothing to disclose

Conflict of Interest Policy/Disclosure Statement

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Global Academy for Medical Education. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

In order to receive credit for this activity, participants must complete the activity. Participants must also score at least 70% on the posttest and complete the activity evaluations.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Statement of Commercial Support

This activity is supported by an independent educational grant from Otsuka America Pharmaceutical, Inc.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Global Academy for Medical Education do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information for Questions About the Activity

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari.

Radiology Presentations

0.50 CME
University of Florida College of Medicine
The Clinical Significance of Imaging in the Management of ADPKD

The Clinical Significance of Imaging in the Management of ADPKD

Start

Activity Details

Free CME
0.5 AMA PRA Category 1 Credits
Released: May 27, 2020
Expires: May 26, 2021
30 minutes to complete

Target Audience

This activity has been designed to meet the educational needs of radiologists and other health care professionals involved in the diagnosis, treatment and management of patients with autosomal dominant polycystic kidney disease (ADPKD).

Overview

This Expert Exchange webcast is designed to help clinicians better understand the importance of radiologic imaging in the clinical management of patients affected by ADPKD.

Educational Objectives

Upon completion of this activity, participants will be better able to do the following:

  • Recognize the significance of total kidney volume (TKV) in ADPKD
  • Summarize the methods for assessing TKV
  • Recognize atypical vs. typical presentations of PKD
  • Summarize clinical decision-making steps regarding treatment decisions

Faculty

Bohyun Kim, MD, PhD
Chief, GU Section
Professor of Radiology
Mayo Clinic
Rochester, MN


Anjay Rastogi, MD, PhD
Director, PKD Program and CORE Kidney Program
Professor and Clinical Chief, Nephrology
UCLA Geffen School of Medicine
Los Angeles, CA


Financial Support

This activity has been supported by an independent educational grant from Otsuka America Pharmaceutical, Inc.

Providers

Jointly provided by the University of Florida College of Medicine and Novus Medical Education.

Joint Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Florida College of Medicine and Novus Medical Education. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Physician Continuing Medical Education

The University of Florida College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

The University of Florida College of Medicine requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to UF COM policy. UF COM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty
Dr. Kim reports no relevant financial relationships to disclose.
Dr. Rastogi reports the following relevant financial relationships:

  • Speakers Bureau/Advisory Board - Genzyme/Sanofi, Otsuka
  • Research Support - Kadmon, Reata Pharmaceuticals, Sanofi

Planners and Managers
The UF COM and Novus Medical Education planners and managers have nothing to disclose.

Method of Participation

There are no fees for participating and receiving CME credit for this activity. To claim credit, participants must complete the following:

  • Read the educational objectives, accreditation information and faculty disclosures at the beginning of this activity.
  • Complete the pre-test.
  • View the webcast.
  • Complete the post-test and evaluation.
  • Physicians who receive a grade of 80% or better on the post-test and complete the evaluation will receive a CME certificate.
  • All other participants who receive a grade of 80% or better on the post-test and complete the evaluation will receive a Certificate of Participation.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CME Provider

The University of Florida College of Medicine can be contacted at cme-mail@ufl.edu or 352.733.0064.

Activity Details

Free CME
0.5 AMA PRA Category 1 Credits
Released: May 27, 2020
Expires: May 26, 2021
30 minutes to complete

Target Audience

This activity has been designed to meet the educational needs of radiologists and other health care professionals involved in the diagnosis, treatment and management of patients with autosomal dominant polycystic kidney disease (ADPKD).

Overview

This Expert Exchange webcast is designed to help clinicians better understand the importance of radiologic imaging in the clinical management of patients affected by ADPKD.

Educational Objectives

Upon completion of this activity, participants will be better able to do the following:

  • Recognize the significance of total kidney volume (TKV) in ADPKD
  • Summarize the methods for assessing TKV
  • Recognize atypical vs. typical presentations of PKD
  • Summarize clinical decision-making steps regarding treatment decisions

Faculty

Bohyun Kim, MD, PhD
Chief, GU Section
Professor of Radiology
Mayo Clinic
Rochester, MN


Anjay Rastogi, MD, PhD
Director, PKD Program and CORE Kidney Program
Professor and Clinical Chief, Nephrology
UCLA Geffen School of Medicine
Los Angeles, CA


Financial Support

This activity has been supported by an independent educational grant from Otsuka America Pharmaceutical, Inc.

Providers

Jointly provided by the University of Florida College of Medicine and Novus Medical Education.

Joint Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Florida College of Medicine and Novus Medical Education. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Physician Continuing Medical Education

The University of Florida College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

The University of Florida College of Medicine requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to UF COM policy. UF COM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty
Dr. Kim reports no relevant financial relationships to disclose.
Dr. Rastogi reports the following relevant financial relationships:

  • Speakers Bureau/Advisory Board - Genzyme/Sanofi, Otsuka
  • Research Support - Kadmon, Reata Pharmaceuticals, Sanofi

Planners and Managers
The UF COM and Novus Medical Education planners and managers have nothing to disclose.

Method of Participation

There are no fees for participating and receiving CME credit for this activity. To claim credit, participants must complete the following:

  • Read the educational objectives, accreditation information and faculty disclosures at the beginning of this activity.
  • Complete the pre-test.
  • View the webcast.
  • Complete the post-test and evaluation.
  • Physicians who receive a grade of 80% or better on the post-test and complete the evaluation will receive a CME certificate.
  • All other participants who receive a grade of 80% or better on the post-test and complete the evaluation will receive a Certificate of Participation.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CME Provider

The University of Florida College of Medicine can be contacted at cme-mail@ufl.edu or 352.733.0064.

0.25 CME
Global Education Group
The Radiologist's Role in the ADPKD Care Continuum: From Diagnosis to Monitoring Disease Progression

The Radiologist's Role in the ADPKD Care Continuum: From Diagnosis to Monitoring Disease Progression

Start

Activity Details

Free CME
0.25 AMA PRA Category 1 Credit(s)
Released: November 27, 2019
Expires: November 26, 2020
15 minutes to complete

Jointly Provided by


In Collaboration with


Target Audience

Diagnostic and interventional radiologists

Learning Objectives

  • Recognize the radiographic features of ADPKD and how they differ from other renal conditions
  • Discuss optimal strategies for use of MRI in evaluating potential candidates for initiating ADPKD therapy and for monitoring the course of disease progression over time

Activity Description

A concise, 15-minute Video Curbside Consult activity will provide a relaxed, casual atmosphere for two expert faculty – one radiologist and one nephrologist – to discuss effective partnering for improving care for patients with ADPKD. Faculty will be filmed using comfortable and inviting staging to match the collegial style of their discussion. The activity will use video interspersed with interactive questions to engage learners and measure their levels of knowledge and understanding at multiple points. Content will focus on the role of the radiologist in the ADPKD care continuum, including initial diagnosis and ongoing monitoring for disease progression.

Statement of Educational Need

Radiologists are challenged to conduct appropriate imaging studies of patients with renal disease, including ADPKD. Radiologists are underutilizing MRI for monitoring progression of ADPKD and are unaware of the most accurate methods for conducting such imaging studies.

Agenda

  • Brief introduction of ADPKD
  • Need for nephrologist-radiologist partnership
  • Role of radiologists in the ADPKD care continuum
    • ADPKD diagnosis
      • When to suspect ADPKD
      • Establishing an ADPKD diagnosis
      • Guidelines for different age cohorts
      • Use of ultrasound versus other imaging options
    • Monitoring and measurement of ADPKD disease progression
      • When and how often is imaging needed?
      • Use of MRI versus other imaging options (abdominal ultrasound and computed tomography)
  • Recommendations for ongoing radiologist-nephrologist communication
  • Summary of key teaching points

Faculty

Gary Israel, MD
Yale University School of Medicine
New Haven, CT
  • Disclosure:
    • Nothing to disclose


Neera Dahl, MD
Yale University School of Medicine
New Haven, CT
  • Disclosure:
    • Consultant/Independent Contractor: Otsuka America Pharmaceutical, Inc.
    • Advisory Board: Otsuka America Pharmaceutical, Inc.


Planners/Managers:
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Lindsay Borvansky    Nothing to disclose
Andrea Funk    Nothing to disclose
Liddy Knight    Nothing to disclose
Ashley Cann    Nothing to disclose
Ron Schaumburg    Nothing to disclose
Nicola Sirdevan    Nothing to disclose

Conflict of Interest Policy/Disclosure Statement

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Global Academy for Medical Education. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

In order to receive credit for this activity, participants must complete the activity. Participants must also score at least 70% on the posttest and complete the activity evaluations.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Statement of Commercial Support

This activity is supported by an independent educational grant from Otsuka America Pharmaceutical, Inc.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Global Academy for Medical Education do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information for Questions About the Activity

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari.

Activity Details

Free CME
0.25 AMA PRA Category 1 Credit(s)
Released: November 27, 2019
Expires: November 26, 2020
15 minutes to complete

Jointly Provided by


In Collaboration with


Target Audience

Diagnostic and interventional radiologists

Learning Objectives

  • Recognize the radiographic features of ADPKD and how they differ from other renal conditions
  • Discuss optimal strategies for use of MRI in evaluating potential candidates for initiating ADPKD therapy and for monitoring the course of disease progression over time

Activity Description

A concise, 15-minute Video Curbside Consult activity will provide a relaxed, casual atmosphere for two expert faculty – one radiologist and one nephrologist – to discuss effective partnering for improving care for patients with ADPKD. Faculty will be filmed using comfortable and inviting staging to match the collegial style of their discussion. The activity will use video interspersed with interactive questions to engage learners and measure their levels of knowledge and understanding at multiple points. Content will focus on the role of the radiologist in the ADPKD care continuum, including initial diagnosis and ongoing monitoring for disease progression.

Statement of Educational Need

Radiologists are challenged to conduct appropriate imaging studies of patients with renal disease, including ADPKD. Radiologists are underutilizing MRI for monitoring progression of ADPKD and are unaware of the most accurate methods for conducting such imaging studies.

Agenda

  • Brief introduction of ADPKD
  • Need for nephrologist-radiologist partnership
  • Role of radiologists in the ADPKD care continuum
    • ADPKD diagnosis
      • When to suspect ADPKD
      • Establishing an ADPKD diagnosis
      • Guidelines for different age cohorts
      • Use of ultrasound versus other imaging options
    • Monitoring and measurement of ADPKD disease progression
      • When and how often is imaging needed?
      • Use of MRI versus other imaging options (abdominal ultrasound and computed tomography)
  • Recommendations for ongoing radiologist-nephrologist communication
  • Summary of key teaching points

Faculty

Gary Israel, MD
Yale University School of Medicine
New Haven, CT
  • Disclosure:
    • Nothing to disclose


Neera Dahl, MD
Yale University School of Medicine
New Haven, CT
  • Disclosure:
    • Consultant/Independent Contractor: Otsuka America Pharmaceutical, Inc.
    • Advisory Board: Otsuka America Pharmaceutical, Inc.


Planners/Managers:
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Lindsay Borvansky    Nothing to disclose
Andrea Funk    Nothing to disclose
Liddy Knight    Nothing to disclose
Ashley Cann    Nothing to disclose
Ron Schaumburg    Nothing to disclose
Nicola Sirdevan    Nothing to disclose

Conflict of Interest Policy/Disclosure Statement

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Global Academy for Medical Education. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

In order to receive credit for this activity, participants must complete the activity. Participants must also score at least 70% on the posttest and complete the activity evaluations.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Statement of Commercial Support

This activity is supported by an independent educational grant from Otsuka America Pharmaceutical, Inc.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Global Academy for Medical Education do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information for Questions About the Activity

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari.

0.75 CME
Vindico
Optimizing the Use of Screening and Imaging in Women With Dense Breasts

Optimizing the Use of Screening and Imaging in Women With Dense Breasts

Start

Activity Details

Free CME
0.75 AMA PRA Category 1 Credit(s)
Released: November 26, 2019
Expires: November 25, 2020
45 minutes to complete

This activity has been updated to include additional resources. Please check the educational tools section of this activity to access the additional resources.

Accredited By

This continuing medical education activity is provided by

Endorsed by

Target Audience

The intended audience for the activity is radiologists, obstetrician-gynecologists, primary care physicians and other health care professionals involved in imaging, or referral for imaging, of patients with dense breasts.

Learning Objectives

Upon successful completion of the activity, participants should be better able to:

  • Review the effects that dense breasts have on cancer risk, as well as their effect on the interpretation of imaging results used in diagnosis and screening.
  • Summarize evidence-based classification criteria used to measure breast density.
  • Determine when it is appropriate to use advanced imaging in patients with dense breasts.
  • Assess the safety of gadolinium-based contrast agents for use in advanced magnetic resonance imaging.
  • Evaluate processes and procedures that can improve the ordering of conventional and advanced imaging for women with dense breasts.
  • Incorporate processes that improve the multidisciplinary management of patients with dense breasts that are undergoing screening or diagnostic follow-up.

Activity Description

Screening mammography has remained the most useful tool for breast cancer detection and has consistently demonstrated a reduction in breast cancer mortality. Dense breast tissue absorbs significantly more radiation during mammography than fatty breast tissue, reducing the accuracy of mammography in women with this condition. However, other imaging modalities exist to increase the accuracy of detecting cancer in dense breast tissue. In this continuing medical education panel discussion, expert physicians from multiple fields will explore alternative imaging modalities for examining breast tissue, in addition to mammography, to diagnose breast cancer in women.

Faculty

Activity Chair:
Deepa Sheth, MD
Assistant Professor of Radiology
Breast Imaging Center
University of Chicago Medicine
Chicago, IL
  • Disclosure: No relevant financial relationships to disclose.


Faculty:
Susan Hong, MD, MPH
Director of Cancer Survivorship
Associate Professor of Medicine and Surgery
University of Illinois
Chicago, IL
  • Disclosure: No relevant financial relationships to disclose.


Iris Romero, MD, MS
Associate Professor
Department of Ob/Gyn
University of Chicago Medicine
Chicago, IL
  • Disclosure: No relevant financial relationships to disclose.


Reviewer:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
  • Disclosure: No relevant financial relationships to disclose.
Vindico Medical Education Staff:
  • Disclosure: No relevant financial relationships to disclose.

Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Conflict of Interest Policy/Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears above.

Accreditation Statement

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation of Credit

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the CME content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Statement of Commercial Support

This activity is supported by an educational grant from Guerbet LLC.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

Disclaimer

The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at CME@VindicoCME.com

Activity Details

Free CME
0.75 AMA PRA Category 1 Credit(s)
Released: November 26, 2019
Expires: November 25, 2020
45 minutes to complete

This activity has been updated to include additional resources. Please check the educational tools section of this activity to access the additional resources.

Accredited By

This continuing medical education activity is provided by

Endorsed by

Target Audience

The intended audience for the activity is radiologists, obstetrician-gynecologists, primary care physicians and other health care professionals involved in imaging, or referral for imaging, of patients with dense breasts.

Learning Objectives

Upon successful completion of the activity, participants should be better able to:

  • Review the effects that dense breasts have on cancer risk, as well as their effect on the interpretation of imaging results used in diagnosis and screening.
  • Summarize evidence-based classification criteria used to measure breast density.
  • Determine when it is appropriate to use advanced imaging in patients with dense breasts.
  • Assess the safety of gadolinium-based contrast agents for use in advanced magnetic resonance imaging.
  • Evaluate processes and procedures that can improve the ordering of conventional and advanced imaging for women with dense breasts.
  • Incorporate processes that improve the multidisciplinary management of patients with dense breasts that are undergoing screening or diagnostic follow-up.

Activity Description

Screening mammography has remained the most useful tool for breast cancer detection and has consistently demonstrated a reduction in breast cancer mortality. Dense breast tissue absorbs significantly more radiation during mammography than fatty breast tissue, reducing the accuracy of mammography in women with this condition. However, other imaging modalities exist to increase the accuracy of detecting cancer in dense breast tissue. In this continuing medical education panel discussion, expert physicians from multiple fields will explore alternative imaging modalities for examining breast tissue, in addition to mammography, to diagnose breast cancer in women.

Faculty

Activity Chair:
Deepa Sheth, MD
Assistant Professor of Radiology
Breast Imaging Center
University of Chicago Medicine
Chicago, IL
  • Disclosure: No relevant financial relationships to disclose.


Faculty:
Susan Hong, MD, MPH
Director of Cancer Survivorship
Associate Professor of Medicine and Surgery
University of Illinois
Chicago, IL
  • Disclosure: No relevant financial relationships to disclose.


Iris Romero, MD, MS
Associate Professor
Department of Ob/Gyn
University of Chicago Medicine
Chicago, IL
  • Disclosure: No relevant financial relationships to disclose.


Reviewer:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
  • Disclosure: No relevant financial relationships to disclose.
Vindico Medical Education Staff:
  • Disclosure: No relevant financial relationships to disclose.

Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Conflict of Interest Policy/Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears above.

Accreditation Statement

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation of Credit

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the CME content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Statement of Commercial Support

This activity is supported by an educational grant from Guerbet LLC.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

Disclaimer

The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at CME@VindicoCME.com